The original rise of Sildenafil presented a considerable prospect for the market, but its exclusivity has expired , creating a challenging landscape. Alternative versions have appeared in the space , diminishing sales and putting a strain on profit percentages . While leading pharmaceutical companies continue a foothold in this field , the outlook